Physician profile
Charles Oh
NPI 1780689042
$4,905.77
in general payments reported to CMS, 2019-2025
18 companies · $552 in 2025
The $552 reported for 2025 was more than what 80% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $265 · 2020: $280 · 2021: $785 · 2022: $533 · 2023: $2,059 · 2024: $431 · 2025: $552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,096 · Travel and Lodging: $893 · Education: $52.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,096.37 |
| Travel and Lodging | $893.43 |
| Education | $52.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $1,320.98 | 2020-2025 | |
| Glaxosmithkline, LLC. | $1,045.65 | 2021-2025 | Nucala |
| Optinose US, INC. | $822.25 | 2019-2025 | |
| Genzyme Corporation | $516.96 | 2019-2024 | |
| Intersect Ent, INC. | $311.47 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $250.25 | 2019-2024 | Dupixent |
| Medtronic, INC. | $129.63 | 2023 | Propel |
| Stryker Corporation | $124.86 | 2019-2025 | Clarifix |
| Alk-Abello, INC | $92.37 | 2019-2023 | Grastek, Odactra, Ragwitek |
| Astrazeneca Pharmaceuticals LP | $83.22 | 2019 | |
| Sanofi-Aventis U.S. LLC | $52.99 | 2025 | |
| Neurent Medical Limited | $29.76 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| 3b Medical, INC. | $28.33 | 2024 | Luna |
| Inspire Medical Systems, INC. | $27.85 | 2023 | Inspire |
| Integra Lifesciences Corporation | $24.59 | 2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $16.90 | 2023 | |
| Arbor Pharmaceuticals, INC. | $15.71 | 2020 | |
| Acclarent, INC | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Oh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.